Literature DB >> 25760230

Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.

Matthew S Painschab1, Gary E Malpartida, Victor G Dávila-Roman, Robert H Gilman, Todd M Kolb, Fabiola León-Velarde, J Jaime Miranda, William Checkley.   

Abstract

Painschab, Matthew S., Gary E. Malpartida, Victor G. Davila-Roman, Robert H. Gilman, Todd M. Kolb, Fabiola Leon-Velarde, J. Jaime Miranda, and William Checkley. Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru. High Alt Med Biol 16:26-33, 2015.-Long-term residence at high altitude is associated with the development of chronic mountain sickness (CMS), which is characterized by excessive erythrocytosis (EE). EE occurs under chronic hypoxia, and a strongly selected mutation in hypoxia-inducible factor 2α (HIF2A) has been found in native Tibetans that correlates with having a normal hemoglobin at high altitude. We sought to evaluate differences in plasma levels of four HIF-responsive proteins in 20 participants with EE (hemoglobin >21 g/dL in men and >19 in women) and in 20 healthy, age- and sex-matched participants without EE living at high altitude in Puno, Peru. We performed ELISA to measure plasma levels of the four HIF-responsive proteins: vascular endothelial growth factor (VEGF), soluble VEGF receptor 1 (sVEGF-R1), endothelin-1, and erythropoietin. As a secondary aim, we evaluated the association between HIF-responsive proteins and echocardiography-estimated pulmonary artery systolic pressure (PASP) in a subset of 26 participants. sVEGF-R1 was higher in participants with vs. without EE (mean 107 pg/mL vs. 90 pg/mL; p=0.007). Although plasma concentrations of endothelin-1, VEGF, and erythropoietin were higher in participants with vs. without EE, they did not achieve statistical significance (all p>0.25). Both sVEGF-R1 (p=0.04) and erythropoietin (p=0.04) were positively associated with PASP after adjustment for age, sex, and BMI. HIF-responsive proteins may play a pathophysiological role in altitude-related, chronic diseases but our results did not show consistent changes in all measured HIF-responsive proteins. Larger studies are needed to evaluate for additional genetic and environmental risk factors.

Entities:  

Keywords:  EPO; HIF; VEGF; chronic mountain sickness; pulmonary hypertension

Mesh:

Substances:

Year:  2015        PMID: 25760230      PMCID: PMC4376286          DOI: 10.1089/ham.2014.1086

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  40 in total

1.  Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders.

Authors:  Cynthia M Beall; Gianpiero L Cavalleri; Libin Deng; Robert C Elston; Yang Gao; Jo Knight; Chaohua Li; Jiang Chuan Li; Yu Liang; Mark McCormack; Hugh E Montgomery; Hao Pan; Peter A Robbins; Kevin V Shianna; Siu Cheung Tam; Ngodrop Tsering; Krishna R Veeramah; Wei Wang; Puchung Wangdui; Michael E Weale; Yaomin Xu; Zhe Xu; Ling Yang; M Justin Zaman; Changqing Zeng; Li Zhang; Xianglong Zhang; Pingcuo Zhaxi; Yong Tang Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Vascular endothelial growth factor (VEGF) - part 1: in physiology and pathophysiology.

Authors:  Dariusz Kajdaniuk; Bogdan Marek; Halina Borgiel-Marek; Beata Kos-Kudła
Journal:  Endokrynol Pol       Date:  2011       Impact factor: 1.582

Review 3.  Mechanisms of ET-1-induced endothelial dysfunction.

Authors:  Marc Iglarz; Martine Clozel
Journal:  J Cardiovasc Pharmacol       Date:  2007-12       Impact factor: 3.105

4.  Sequencing of 50 human exomes reveals adaptation to high altitude.

Authors:  Xin Yi; Yu Liang; Emilia Huerta-Sanchez; Xin Jin; Zha Xi Ping Cuo; John E Pool; Xun Xu; Hui Jiang; Nicolas Vinckenbosch; Thorfinn Sand Korneliussen; Hancheng Zheng; Tao Liu; Weiming He; Kui Li; Ruibang Luo; Xifang Nie; Honglong Wu; Meiru Zhao; Hongzhi Cao; Jing Zou; Ying Shan; Shuzheng Li; Qi Yang; Peixiang Ni; Geng Tian; Junming Xu; Xiao Liu; Tao Jiang; Renhua Wu; Guangyu Zhou; Meifang Tang; Junjie Qin; Tong Wang; Shuijian Feng; Guohong Li; Jiangbai Luosang; Wei Wang; Fang Chen; Yading Wang; Xiaoguang Zheng; Zhuo Li; Zhuoma Bianba; Ge Yang; Xinping Wang; Shuhui Tang; Guoyi Gao; Yong Chen; Zhen Luo; Lamu Gusang; Zheng Cao; Qinghui Zhang; Weihan Ouyang; Xiaoli Ren; Huiqing Liang; Huisong Zheng; Yebo Huang; Jingxiang Li; Lars Bolund; Karsten Kristiansen; Yingrui Li; Yong Zhang; Xiuqing Zhang; Ruiqiang Li; Songgang Li; Huanming Yang; Rasmus Nielsen; Jun Wang; Jian Wang
Journal:  Science       Date:  2010-07-02       Impact factor: 47.728

5.  Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

Authors:  H P Gerber; F Condorelli; J Park; N Ferrara
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

Review 6.  Primary pulmonary hypertension.

Authors:  James R Runo; James E Loyd
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 7.  Gene expression in chronic high altitude diseases.

Authors:  Fabiola León-Velarde; Olga Mejía
Journal:  High Alt Med Biol       Date:  2008       Impact factor: 1.981

8.  Erythropoietin upregulation in pulmonary arterial hypertension.

Authors:  Vanesa A Karamanian; Michael Harhay; Gregory R Grant; Harold I Palevsky; William E Grizzle; Roham T Zamanian; Kaori Ihida-Stansbury; Darren B Taichman; Steven M Kawut; Peter L Jones
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

9.  Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia.

Authors:  Jorge Soliz; Max Gassmann; Vincent Joseph
Journal:  J Physiol       Date:  2007-06-21       Impact factor: 5.182

10.  Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population.

Authors:  Jose R Espinoza; Giancarlo Alvarez; Fabiola León-Velarde; Hugo F Ju Preciado; Jose-Luis Macarlupu; Maria Rivera-Ch; Jorge Rodriguez; Judith Favier; Anne-Paule Gimenez-Roqueplo; Jean-Paul Richalet
Journal:  High Alt Med Biol       Date:  2014-06       Impact factor: 1.981

View more
  3 in total

1.  Excessive Iron Availability Caused by Disorders of Interleukin-10 and Interleukin-22 Contributes to High Altitude Polycythemia.

Authors:  Yun-Sheng Liu; He Huang; Si-Min Zhou; Huai-Jun Tian; Peng Li
Journal:  Front Physiol       Date:  2018-05-22       Impact factor: 4.566

Review 2.  Towards sustainable partnerships in global health: the case of the CRONICAS Centre of Excellence in Chronic Diseases in Peru.

Authors:  J Jaime Miranda; Antonio Bernabé-Ortiz; Francisco Diez-Canseco; Germán Málaga; María K Cárdenas; Rodrigo M Carrillo-Larco; María Lazo-Porras; Miguel Moscoso-Porras; M Amalia Pesantes; Vilarmina Ponce; Ricardo Araya; David Beran; Peter Busse; Oscar Boggio; William Checkley; Patricia J García; Luis Huicho; Fabiola León-Velarde; Andrés G Lescano; David C Mohr; William Pan; David Peiris; Pablo Perel; Cristina Rabadán-Diehl; Maria Rivera-Chira; Katherine Sacksteder; Liam Smeeth; Antonio J Trujillo; Jonathan C K Wells; Lijing L Yan; Héctor H García; Robert H Gilman
Journal:  Global Health       Date:  2016-06-02       Impact factor: 4.185

3.  Associations of high altitude polycythemia with polymorphisms in EPAS1, ITGA6 and ERBB4 in Chinese Han and Tibetan populations.

Authors:  Yiduo Zhao; Zhiying Zhang; Lijun Liu; Yao Zhang; Xiaowei Fan; Lifeng Ma; Jing Li; Yuan Zhang; Haijin He; Longli Kang
Journal:  Oncotarget       Date:  2017-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.